Tonix Pharmaceuticals Stock News

Tonix Pharmaceuticals Holding Corp. (TNXP) with the stream of -2.38% also noticed, India Marathon Oil Corporation (MRO) encountered a rapid change of 2.12% in the last hour of Wednesdays trading The post Trending Hot Stocks Analysis: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Marathon Oil Corporation (NYSE:MRO) appeared first on Stocks Equity .

The company's path to regulatory approval for a key pipeline drug just got a bit shorter.

The company's path to regulatory approval for a key pipeline drug just got a bit shorter.

The FDA has signed off Tonix Pharmaceuticals Holding Corp''s (NASDAQ: TNXP ) Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine. TNX-1900 is intranasal potentiated oxytocin designed for the prevention of migraine headaches in chronic migraineurs. The program is expected to qualify for the 505(b)(2) pathway Full story available on Benzinga.com

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Synlogic Presents Positive Phase 2 Data For Synthetic Biologic Treatment In Inherited Metabolic Disord

Approximately Four Million in U.S. Suffer from Chronic Migraine

Tonix Pharmaceuticals Holding Corp. (TNXP) with the stream of -3.03% also noticed, India Virgin Galactic Holdings, Inc. (SPCE) encountered a rapid change of -0.87% in the last hour of Mondays The post Is The Stock Worthy? Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Virgin Galactic Holdings, Inc. (NYSE:SPCE) appeared first on Stocks Equity .

Northern Trust Corp grew its holdings in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) by 389.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,108,226 shares of the companys stock after purchasing an additional 2,472,687 shares during the period. Northern Trust Corp owned about 0.87% []

The FDA has signed off Tonix Pharmaceuticals Holding Corp's (NASDAQ: TNXP) Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.  TNX-1900 is intranasal po

The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) increased by over 25% pre-market today. This is why it happened.

Early Studies in vitro Show that TNX-3500 is a Potent Antiviral Against Multiple Variants of SARS-CoV-2, the Cause of COVID-19, and Potentiates Remdesivir Early Studies in vitro Show that TNX-3500 is

Early Studies in vitro Show that TNX-3500 is a Potent Antiviral Against Multiple Variants of SARS-CoV-2, the Cause of COVID-19, and Potentiates Remdesivir Early Studies in vitro Show that TNX-3500 is a Potent Antiviral Against Multiple Variants of SARS-CoV-2, the Cause of COVID-19, and Potentiates Remdesivir

In the latest trading session, 4.55 million Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares changed hands as the companys beta touched 1.16. With the companys most recent per share price at $0.54 changed hands at -$0.04 or -6.11% at last look, the market valuation stands at $253.32M. TNXPs current price is a discount, trading about -292.59% Why To Invest In Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Stock? Read More »

The company secures a potentially crucial piece of intellectual property.